קלופיד 75 מ"ג

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Wirkstoff:

CLOPIDOGREL 75 MG

Verfügbar ab:

TARO INTERNATIONAL LTD

ATC-Code:

B01AC04

Darreichungsform:

FILM COATED TABLETS

Verabreichungsweg:

PER OS

Hergestellt von:

PHARMATHEN S.A., GREECE

Therapiegruppe:

CLOPIDOGREL

Anwendungsgebiete:

Clopidogrel is indicated in adults for the prevention of atherothrombotic events as follows:Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.Patients suffering from Acute Coronary Syndrome- Non-ST segment elevation acute coronary syndrome (unstable angina/non-Q-wave myocardial infarction (MI)), including patients undergoing a stent replacement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA). - ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy

Berechtigungsdatum:

2011-06-01